439 related articles for article (PubMed ID: 33540624)
1. Gut Microbiota at the Intersection of Alcohol, Brain, and the Liver.
Gupta H; Suk KT; Kim DJ
J Clin Med; 2021 Feb; 10(3):. PubMed ID: 33540624
[TBL] [Abstract][Full Text] [Related]
2. The Role of Gut Bacteria and Fungi in Alcohol-Associated Liver Disease.
Chen L; Zhu Y; Hou X; Yang L; Chu H
Front Med (Lausanne); 2022; 9():840752. PubMed ID: 35308525
[TBL] [Abstract][Full Text] [Related]
3. The gut-liver-kidney axis: Novel regulator of fatty liver associated chronic kidney disease.
Raj D; Tomar B; Lahiri A; Mulay SR
Pharmacol Res; 2020 Feb; 152():104617. PubMed ID: 31881272
[TBL] [Abstract][Full Text] [Related]
4. Alcohol or Gut Microbiota: Who Is the Guilty?
Meroni M; Longo M; Dongiovanni P
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540133
[TBL] [Abstract][Full Text] [Related]
5. Role of Gut Dysbiosis in Liver Diseases: What Have We Learned So Far?
Fukui H
Diseases; 2019 Nov; 7(4):. PubMed ID: 31726747
[TBL] [Abstract][Full Text] [Related]
6. Alcoholic liver disease: the gut microbiome and liver cross talk.
Hartmann P; Seebauer CT; Schnabl B
Alcohol Clin Exp Res; 2015 May; 39(5):763-75. PubMed ID: 25872593
[TBL] [Abstract][Full Text] [Related]
7. The Beneficial Effects of Natural Extracts and Bioactive Compounds on the Gut-Liver Axis: A Promising Intervention for Alcoholic Liver Disease.
Zhao L; Wang S; Zhang N; Zhou J; Mehmood A; Raka RN; Zhou F; Zhao L
Antioxidants (Basel); 2022 Jun; 11(6):. PubMed ID: 35740108
[TBL] [Abstract][Full Text] [Related]
8. Role of gut bacterial and non-bacterial microbiota in alcohol-associated liver disease: Molecular mechanisms, biomarkers, and therapeutic prospective.
Zafari N; Velayati M; Fahim M; Maftouh M; Pourali G; Khazaei M; Nassiri M; Hassanian SM; Ghayour-Mobarhan M; Ferns GA; Kiani MA; Avan A
Life Sci; 2022 Sep; 305():120760. PubMed ID: 35787997
[TBL] [Abstract][Full Text] [Related]
9. Intestinal HIF-1α deletion exacerbates alcoholic liver disease by inducing intestinal dysbiosis and barrier dysfunction.
Shao T; Zhao C; Li F; Gu Z; Liu L; Zhang L; Wang Y; He L; Liu Y; Liu Q; Chen Y; Donde H; Wang R; Jala VR; Barve S; Chen SY; Zhang X; Chen Y; McClain CJ; Feng W
J Hepatol; 2018 Oct; 69(4):886-895. PubMed ID: 29803899
[TBL] [Abstract][Full Text] [Related]
10. Gut-liver axis in alcoholic liver disease.
Szabo G
Gastroenterology; 2015 Jan; 148(1):30-6. PubMed ID: 25447847
[TBL] [Abstract][Full Text] [Related]
11. Probiotics-Based Treatment as an Integral Approach for Alcohol Use Disorder in Alcoholic Liver Disease.
Fuenzalida C; Dufeu MS; Poniachik J; Roblero JP; Valenzuela-Pérez L; Beltrán CJ
Front Pharmacol; 2021; 12():729950. PubMed ID: 34630107
[TBL] [Abstract][Full Text] [Related]
12. Fecal microbiota manipulation prevents dysbiosis and alcohol-induced liver injury in mice.
Ferrere G; Wrzosek L; Cailleux F; Turpin W; Puchois V; Spatz M; Ciocan D; Rainteau D; Humbert L; Hugot C; Gaudin F; Noordine ML; Robert V; Berrebi D; Thomas M; Naveau S; Perlemuter G; Cassard AM
J Hepatol; 2017 Apr; 66(4):806-815. PubMed ID: 27890791
[TBL] [Abstract][Full Text] [Related]
13. Targeting the gut barrier for the treatment of alcoholic liver disease.
Zhou Z; Zhong W
Liver Res; 2017 Dec; 1(4):197-207. PubMed ID: 30034913
[TBL] [Abstract][Full Text] [Related]
14. Are Probiotics Effective in Targeting Alcoholic Liver Diseases?
Hong M; Han DH; Hong J; Kim DJ; Suk KT
Probiotics Antimicrob Proteins; 2019 Jun; 11(2):335-347. PubMed ID: 29687200
[TBL] [Abstract][Full Text] [Related]
15. Inulin Ameliorates Alcoholic Liver Disease via Suppressing LPS-TLR4-Mψ Axis and Modulating Gut Microbiota in Mice.
Yang X; He F; Zhang Y; Xue J; Li K; Zhang X; Zhu L; Wang Z; Wang H; Yang S
Alcohol Clin Exp Res; 2019 Mar; 43(3):411-424. PubMed ID: 30589437
[TBL] [Abstract][Full Text] [Related]
16. Alcoholic liver disease: focus on prodromal gut health.
Park B; Lee HR; Lee YJ
J Dig Dis; 2016 Aug; 17(8):493-500. PubMed ID: 27356233
[TBL] [Abstract][Full Text] [Related]
17. Intestinal dysbiosis and permeability: the yin and yang in alcohol dependence and alcoholic liver disease.
Stärkel P; Leclercq S; de Timary P; Schnabl B
Clin Sci (Lond); 2018 Jan; 132(2):199-212. PubMed ID: 29352076
[TBL] [Abstract][Full Text] [Related]
18. Gut microbiota and host metabolism in liver cirrhosis.
Usami M; Miyoshi M; Yamashita H
World J Gastroenterol; 2015 Nov; 21(41):11597-608. PubMed ID: 26556989
[TBL] [Abstract][Full Text] [Related]
19. Non-celiac gluten sensitivity triggers gut dysbiosis, neuroinflammation, gut-brain axis dysfunction, and vulnerability for dementia.
Daulatzai MA
CNS Neurol Disord Drug Targets; 2015; 14(1):110-31. PubMed ID: 25642988
[TBL] [Abstract][Full Text] [Related]
20. Gut microbiota-modulating agents in alcoholic liver disease: Links between host metabolism and gut microbiota.
Jung JH; Kim SE; Suk KT; Kim DJ
Front Med (Lausanne); 2022; 9():913842. PubMed ID: 35935787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
